Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,156,899
-$227,276 QoQ
Shares Held
48,044
-2.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#1,241
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Strategic Investment Advisors / MI holds $15,039,322 across 11 Drug Manufacturers - General names. PFE ranks #4 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
14,165 | $3,564,480 | |
| 2 | LLY |
ELI LILLY & Co
|
2,376 | $2,849,845 | |
| 3 | AMGN |
Amgen Inc
|
7,664 | $2,775,287 | |
| 4 | PFE |
Pfizer Inc
This page
|
48,044 | $1,156,899 | |
| 5 | JNJ |
Johnson & Johnson
|
4,524 | $1,148,960 | |
| 6 | SNY |
Sanofi
|
25,867 | $1,103,486 | |
| 7 | MRK |
Merck & Co., Inc.
|
6,694 | $860,179 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
5,340 | $674,655 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,156,899 | 48,044 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,384,175 | 49,294 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $1,005,910 | 40,398 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,100,685 | 43,198 | Shares | Sole | 2025-12-17 | |
| 2025-06-30 | $1,065,638 | 43,962 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,190,929 | 46,998 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $2,282,402 | 86,031 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $2,613,976 | 90,324 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $2,412,463 | 86,221 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $2,372,319 | 85,489 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $2,406,527 | 83,589 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $2,943,970 | 88,754 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $3,363,335 | 91,694 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,839,973 | 94,117 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $3,650,235 | 71,238 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $2,980,756 | 68,116 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $3,389,232 | 64,643 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,859,878 | 55,242 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $3,187,400 | 53,978 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $2,337,636 | 54,351 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $2,065,885 | 52,755 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $1,902,002 | 52,498 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $1,556,253 | 42,278 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $765,487 | 20,858 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $604,198 | 18,477 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $578,641 | 17,728 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||